UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A phase 1b/2 study of vosaroxin in combination with cytarabine in patients with relapsed or refractory acute myeloid leukemia

Haematologica (Roma), 2015-02, Vol.100 (2), p.231-237

2015

Volltextzugriff (PDF)

Vasospastic amaurosis fugax

Journal of neurology, neurosurgery and psychiatry, 2003-02, Vol.74 (2), p.149-149

2003

Volltextzugriff (PDF)

Interleukin-2 associated linear IgA bullous dermatosis

Journal of the American Academy of Dermatology, 1996-11, Vol.35 (5), p.865-867

1996

Volltextzugriff (PDF)

Adaptive design of VALOR, a phase III trial of vosaroxin or placebo in combination with cytarabine for patients with first relapsed or refractory acute myeloid leukemia

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.TPS201-TPS201

2011

Volltextzugriff (PDF)

Final results of a phase II pharmacokinetic/pharmacodynamic (PK/PD) study of combination voreloxin and cytarabine in patients with relapsed or refractory acute myeloid leukemia

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.6526-6526

2010

Volltextzugriff (PDF)

Voreloxin single-agent treatment of older patients (60 years or older) with previously untreated acute myeloid leukemia: Final results from a phase II study with three schedules

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.6525-6525

2010

Volltextzugriff (PDF)

Final results of a phase II study of voreloxin in women with platinum-resistant ovarian cancer

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.5002-5002

2010

Volltextzugriff (PDF)

A phase I trial of sns-314, a novel and selective pan-aurora kinase inhibitor, in advanced solid tumor patients

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.2536-2536

2009

Volltextzugriff (PDF)

A phase II trial of voreloxin in women with platinum-resistant ovarian cancer

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.5559-5559

2009

Volltextzugriff (PDF)

Phase Ib/II pharmacokinetic/pharmacodynamic (PK/PD) study of combination voreloxin and cytarabine in relapsed or refractory AML patients

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.7005-7005

2009

Volltextzugriff (PDF)

Blood velocity in the ophthalmic artery in normal subjects and patients with endophthalmitis

Investigative ophthalmology & visual science, 1990-09, Vol.31 (9), p.1919-1923

1990

Volltextzugriff (PDF)

A phase II trial of SNS-595 in women with platinum resistant epithelial ovarian cancer

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.5582-5582

2008

Volltextzugriff (PDF)

Bone impactors--new instruments for spinal decompression

Spine (Philadelphia, Pa. 1976), 1987-11, Vol.12 (9), p.955-955

Michelson, G K

1987

Volltextzugriff (PDF)

Review of inhaled recombinant interleukin-2 (rIL-2) in patients with renal cell carcinoma with pulmonary metastases

Journal of clinical oncology, 2005-06, Vol.23 (16_suppl), p.4756-4756

2005

Volltextzugriff (PDF)

A phase 1, pharmacokinetic (PK) and pharmacodynamic (PD) study of CHIR-258, a novel oral multiple receptor tyrosine kinase (RTK) inhibitor

Journal of clinical oncology, 2006-06, Vol.24 (18_suppl), p.3043-3043

2006

Volltextzugriff (PDF)

Phase I trial of chir-258 in multiple myeloma

Journal of clinical oncology, 2006-06, Vol.24 (18_suppl), p.17502-17502

2006

Volltextzugriff (PDF)

Phase I study of CT-2106 (polyglutamate camptothecin) in patients with advanced malignancies

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.3127-3127

2004

Volltextzugriff (PDF)

Phase I study of CT-2106 (polyglutamate camptothecin) in patients with advanced malignancies

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.3127-3127

2004

Volltextzugriff (PDF)

Retinal haemorrhage in P falciparum malaria

The Lancet (British edition), 2002-08, Vol.360 (9332), p.515-515

2002

Volltextzugriff (PDF)

Regulation of rat ileal water absorption by central α2 adrenergic receptors

Digestive diseases and sciences, 1990-06, Vol.35 (6), p.737-742

1990

Volltextzugriff (PDF)

Use of Colons in Titles and Journal Status in Industrial Relations Journals

Psychological reports, 1994-04, Vol.74 (2), p.657-658

Michelson, Grant

1994

Volltextzugriff (PDF)

Central administration of benzodiazepines alters water absorption by the rat ileum in vivo

Gastroenterology (New York, N.Y. 1943), 1987-08, Vol.93 (2), p.330-334

1987

Volltextzugriff (PDF)

Changing leaders: the board's role in CEO succession ... roundtable discussion

Harvard business review, 1999-05, Vol.77 (3), p.96-209

1999

Volltextzugriff (PDF)

LETTERS

Spine (Philadelphia, Pa. 1976), 1987-11, Vol.12 (9), p.955

MICHELSON, G. KARLIN

1987

Volltextzugriff (PDF)

CHANGING LEADERS THE BOARD'S ROLE IN CEO SUCCESSION

Harvard business review, 1999-05, Vol.77 (3), p.96

1999

Volltextzugriff (PDF)

1 – 25 von 340

Suche als RSS-Feed

Aktive Filter

KollektionNUS Single-Journal Subscriptions

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(316)
Mit Volltextzugriff
(268)

Publikationsform

Sprache

Englisch
(339)
Französisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

The Astrophysical Journal
(111)
Astrophysical Journal/the astrophysical Journal
(37)
Journal Of Clinical Oncology
(14)
Nature
(12)
Physical Review Letters
(10)
Science
(10)
Pediatrics
(8)
The American Journal Of Cardiology
(8)
Astronomy And Astrophysics
(7)
Blood
(7)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A phase 1b/2 study of vosaroxin in combination with cytarabine in patients with relapsed or refractory acute myeloid leukemia

Vasospastic amaurosis fugax

Interleukin-2 associated linear IgA bullous dermatosis

Adaptive design of VALOR, a phase III trial of vosaroxin or placebo in combination with cytarabine for patients with first relapsed or refractory acute myeloid leukemia

Final results of a phase II pharmacokinetic/pharmacodynamic (PK/PD) study of combination voreloxin and cytarabine in patients with relapsed or refractory acute myeloid leukemia

Voreloxin single-agent treatment of older patients (60 years or older) with previously untreated acute myeloid leukemia: Final results from a phase II study with three schedules

Final results of a phase II study of voreloxin in women with platinum-resistant ovarian cancer

A phase I trial of sns-314, a novel and selective pan-aurora kinase inhibitor, in advanced solid tumor patients

A phase II trial of voreloxin in women with platinum-resistant ovarian cancer

Phase Ib/II pharmacokinetic/pharmacodynamic (PK/PD) study of combination voreloxin and cytarabine in relapsed or refractory AML patients

Blood velocity in the ophthalmic artery in normal subjects and patients with endophthalmitis

A phase II trial of SNS-595 in women with platinum resistant epithelial ovarian cancer

Bone impactors--new instruments for spinal decompression

Review of inhaled recombinant interleukin-2 (rIL-2) in patients with renal cell carcinoma with pulmonary metastases

A phase 1, pharmacokinetic (PK) and pharmacodynamic (PD) study of CHIR-258, a novel oral multiple receptor tyrosine kinase (RTK) inhibitor

Phase I trial of chir-258 in multiple myeloma

Phase I study of CT-2106 (polyglutamate camptothecin) in patients with advanced malignancies

Phase I study of CT-2106 (polyglutamate camptothecin) in patients with advanced malignancies

Retinal haemorrhage in P falciparum malaria

Regulation of rat ileal water absorption by central α2 adrenergic receptors

Use of Colons in Titles and Journal Status in Industrial Relations Journals

Central administration of benzodiazepines alters water absorption by the rat ileum in vivo

Changing leaders: the board's role in CEO succession ... roundtable discussion

LETTERS

CHANGING LEADERS THE BOARD'S ROLE IN CEO SUCCESSION

Aktive Filter

Suchergebnisse filtern